Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - COST OF REVENUE
Cost of Revenue RGNX - REGENXBIO Inc.
37.2 M
LAST VALUE
-15.27%
2 YEAR CAGR
31.02%
5 YEAR CAGR
60.70%
10 YEAR CAGR